Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04134936 |
|---|---|
| Brief Title: | Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL |
| First Submitted : | October 11, 2019 |
| First Submitted that Met QC Criteria : | October 21, 2019 |
| First Posted : | October 22, 2019 |
| Last Update Submitted that Met QC Criteria : | March 14, 2023 |
| Last Update Posted : | March 15, 2023 |